Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2017

01-08-2017 | Clinical trial

First international consensus conference on standardization of oncoplastic breast conserving surgery

Authors: Walter P. Weber, Savas D. Soysal, Mahmoud El-Tamer, Virgilio Sacchini, Michael Knauer, Christoph Tausch, Nik Hauser, Andreas Günthert, Yves Harder, Elisabeth A. Kappos, Fabienne Schwab, Florian Fitzal, Peter Dubsky, Vesna Bjelic-Radisic, Roland Reitsamer, Rupert Koller, Jörg Heil, Markus Hahn, Jens-Uwe Blohmer, Jürgen Hoffmann, Christine Solbach, Christoph Heitmann, Bernd Gerber, Martin Haug, Christian Kurzeder

Published in: Breast Cancer Research and Treatment | Issue 1/2017

Login to get access

Abstract

Purpose

To obtain consensus recommendations for the standardization of oncoplastic breast conserving surgery (OPS) from an international panel of experts in breast surgery including delegates from the German, Austrian and Swiss societies of senology.

Methods

A total of 52 questions were addressed by electronic voting. The panel’s recommendations were put into context with current evidence and the report was circled in an iterative open email process until consensus was obtained.

Results

The panelists considered OPS safe and effective for improving aesthetic outcomes and broadening the indication for breast conserving surgery (BCS) towards larger tumors. A slim majority believed that OPS reduces the rate of positive margins; however, there was consensus that OPS is associated with an increased risk of complications compared to conventional BCS. The panel strongly endorsed patient-reported outcomes measurement, and recommended selected scales of the Breast-Q™-Breast Conserving Therapy Module for that purpose. The Clough bi-level classification was recommended for standard use in clinical practice for indicating, planning and performing OPS, and the Hoffmann classification for surgical reports and billing purposes. Mastopexy and reduction mammoplasty were the only two recognized OPS procedure categories supported by a majority of the panel. Finally, the experts unanimously supported the statement that every OPS procedure should be tailored to each individual patient.

Conclusions

When implemented into clinical practice, the panel recommendations may improve safety and effectiveness of OPS. The attendees agreed that there is a need for prospective multicenter studies to optimize patient selection and for standardized criteria to qualify and accredit OPS training centers.
Appendix
Available only for authorised users
Literature
1.
Benelli L (1990) A new periareolar mammaplasty: the “round block” technique. Aesthet Plast Surg 14:93–100CrossRef
2.
Clough KB, Nos C, Salmon RJ, Soussaline M, Durand JC (1995) Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg 96:363–370CrossRefPubMed
3.
Galimberti V, Zurrida S, Zanini V, Callegari M, Veronesi P, Catania S, Luini A, Greco M, Grisotti A (1993) Central small size breast cancer: how to overcome the problem of nipple and areola involvement. Eur J Cancer 29A:1093–1096CrossRefPubMed
4.
Silverstein MJ, Mai T, Savalia N, Vaince F, Guerra L (2014) Oncoplastic breast conservation surgery: the new paradigm. J Surg Oncol 110:82–89CrossRefPubMed
5.
Anderson BO, Masetti R, Silverstein MJ (2005) Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques. Lancet Oncol 6:145–157CrossRefPubMed
6.
Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM (2010) Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol 17:1375–1391CrossRefPubMed
7.
Hoffmann J, Wallwiener D (2009) Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients. BMC Cancer 9:108CrossRefPubMedPubMedCentral
8.
Iwuchukwu OC, Harvey JR, Dordea M, Critchley AC, Drew PJ (2012) The role of oncoplastic therapeutic mammoplasty in breast cancer surgery–a review. Surg Oncol 21:133–141CrossRefPubMed
9.
10.
Rainsbury RM (2007) Surgery insight: oncoplastic breast-conserving reconstruction–indications, benefits, choices and outcomes. Nat Clin Pract Oncol 4:657–664CrossRefPubMed
11.
Rezai M, Kraemer S, Kimmig R, Kern P (2015) Breast conservative surgery and local recurrence. Breast 24(Suppl 2):S100–S107CrossRefPubMed
12.
Urban C, Lima R, Schunemann E, Spautz C, Rabinovich I, Anselmi K (2011) Oncoplastic principles in breast conserving surgery. Breast 20(Suppl 3):S92–S95CrossRefPubMed
13.
Weber WP, Soysal SD, Fulco I, Barandun M, Babst D, Kalbermatten D, Schaefer DJ, Oertli D, Kappos EA, Haug M (2017) Standardization of oncoplastic breast conserving surgery. Eur J Surg Oncol. doi:10.​1016/​j.​ejso.​2017.​01.​006
14.
Haloua MH, Krekel NM, Winters HA, Rietveld DH, Meijer S, Bloemers FW, van den Tol MP (2013) A systematic review of oncoplastic breast-conserving surgery: current weaknesses and future prospects. Ann Surg 257:609–620CrossRefPubMed
15.
Panhofer P, Ferenc V, Schutz M, Gleiss A, Dubsky P, Jakesz R, Gnant M, Fitzal F (2014) Standardization of morbidity assessment in breast cancer surgery using the Clavien Dindo classification. Int J Surg 12:334–339CrossRefPubMed
16.
Carter SA, Lyons GR, Kuerer HM, Bassett RL Jr, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RF (2016) Operative and oncologic outcomes in 9861 patients with operable breast cancer: single-institution analysis of breast conservation with oncoplastic reconstruction. Ann Surg Oncol. doi:10.​1245/​s10434-016-5407-9 PubMedCentral
17.
De La Cruz L, Blankenship SA, Chatterjee A, Geha R, Nocera N, Czerniecki BJ, Tchou J, Fisher CS (2016) Outcomes After oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review. Ann Surg Oncol 23(10):3247–3258CrossRef
18.
van Maaren MC (2016) de ML, de Bock GH, Jobsen JJ, van DT, Linn SC, Poortmans P, Strobbe LJ, Siesling S: 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol 17:1158–1170CrossRefPubMed
19.
Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M (2014) Society of surgical oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol 21:704–716CrossRefPubMed
20.
Santos G, Urban C, Edelweiss MI, Zucca-Matthes G, de Oliveira VM, Arana GH, Iera M, Rietjens M, de Lima RS, Spautz C, Kuroda F, Anselmi K, Capp E (2015) Long-term comparison of aesthetical outcomes after oncoplastic surgery and lumpectomy in breast cancer patients. Ann Surg Oncol 22:2500–2508CrossRefPubMed
21.
Losken A, Dugal CS, Styblo TM, Carlson GW (2014) A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg 72:145–149CrossRefPubMed
22.
Down SK, Jha PK, Burger A, Hussien MI (2013) Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer. Breast J 19:56–63CrossRefPubMed
23.
Chang EI, Peled AW, Foster RD, Lin C, Zeidler KR, Ewing CA, Alvarado M, Hwang ES, Esserman LJ (2012) Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg 255:1151–1157CrossRefPubMed
24.
Clough KB, Gouveia PF, Benyahi D, Massey EJ, Russ E, Sarfati I, Nos C (2015) Positive margins after oncoplastic surgery for breast cancer. Ann Surg Oncol 22:4247–4253CrossRefPubMed
25.
26.
Gennari R, Griguolo G, Dieci MV, Guarneri V, Tavaniello B, Sibilio A, Conte P (2016) Fat grafting for breast cancer patients: from basic science to clinical studies. Eur J Surg Oncol 42:1088–1102CrossRefPubMed
27.
Masia J, Bordoni D, Pons G, Liuzza C, Castagnetti F, Falco G (2015) Oncological safety of breast cancer patients undergoing free-flap reconstruction and lipofilling. Eur J Surg Oncol 41:612–616CrossRefPubMed
28.
Mestak O, Hromadkova V, Fajfrova M, Molitor M, Mestak J (2016) Evaluation of oncological safety of fat grafting after breast-conserving therapy: a prospective study. Ann Surg Oncol 23:776–781CrossRefPubMed
29.
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ (2009) Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg 124:345–353CrossRefPubMed
30.
Cardoso JS, Cardoso MJ (2007) Towards an intelligent medical system for the aesthetic evaluation of breast cancer conservative treatment. Artif Intell Med 40:115–126CrossRefPubMed
31.
Fitzal F, Krois W, Trischler H, Wutzel L, Riedl O, Kuhbelbock U, Wintersteiner B, Cardoso MJ, Dubsky P, Gnant M, Jakesz R, Wild T (2007) The use of a breast symmetry index for objective evaluation of breast cosmesis. Breast 16:429–435CrossRefPubMed
32.
Cardoso MJ, Cardoso J, Santos AC, Vrieling C, Christie D, Liljegren G, Azevedo I, Johansen J, Rosa J, Amaral N, Saaristo R, Sacchini V, Barros H, Oliveira MC (2007) Factors determining esthetic outcome after breast cancer conservative treatment. Breast J 13:140–146CrossRefPubMed
33.
Fitzal F, Mittlboeck M, Trischler H, Krois W, Nehrer G, Deutinger M, Jakesz R, Gnant M (2008) Breast-conserving therapy for centrally located breast cancer. Ann Surg 247:470–476CrossRefPubMed
34.
Baildam A, Bishop H, Boland G, Dalglish M, Davies L, Fatah F, Gooch H, Harcourt D, Martin L, Rainsbury D, Rayter Z, Sheppard C, Smith J, Weiler-Mithoff E, Winstanley J, Church J (2007) Oncoplastic breast surgery–a guide to good practice. Eur J Surg Oncol 33(Suppl 1):S1–S23PubMed
Metadata
Title
First international consensus conference on standardization of oncoplastic breast conserving surgery
Authors
Walter P. Weber
Savas D. Soysal
Mahmoud El-Tamer
Virgilio Sacchini
Michael Knauer
Christoph Tausch
Nik Hauser
Andreas Günthert
Yves Harder
Elisabeth A. Kappos
Fabienne Schwab
Florian Fitzal
Peter Dubsky
Vesna Bjelic-Radisic
Roland Reitsamer
Rupert Koller
Jörg Heil
Markus Hahn
Jens-Uwe Blohmer
Jürgen Hoffmann
Christine Solbach
Christoph Heitmann
Bernd Gerber
Martin Haug
Christian Kurzeder
Publication date
01-08-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4314-5

Other articles of this Issue 1/2017

Breast Cancer Research and Treatment 1/2017 Go to the issue

Epidemiology

Family history and risk of breast cancer: an analysis accounting for family structure

Preclinical study

Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer

Clinical trial

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

Epidemiology

Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy

Clinical trial

Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery

Clinical trial

Unenhanced magnetic resonance screening using fused diffusion-weighted imaging and maximum-intensity projection in patients with a personal history of breast cancer: role of fused DWI for postoperative screening
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits